Asepha, a pioneering startup in AI-driven pharmacy automation, recently closed a $4 million Seed funding round. Glasswing Ventures and Core Innovation Capital led the oversubscribed investment. Panache, RedBud, and MGV also participated, with follow-on support from Ripple Ventures and Front Row Ventures.
Founded in 2023 by Eunice Wu and Can Uncu, Asepha addresses critical bottlenecks in pharmacy care. Approximately 70% of pharmacies face understaffing issues. Pharmacists spend up to 90% of their time on manual administrative tasks. Asepha's interoperable AI agents streamline these operations.
Advancing Pharmacy Efficiency with AI Agents
Asepha's suite of tools enhances workflow speed and accuracy. An OCR prescription entry agent interprets complex, handwritten prescriptions with 96% accuracy. This dramatically reduces manual data entry. Furthermore, a call agent automates up to 70% of inbound phone calls, freeing staff time. The browser navigation agent performs real-time web-based tasks, managing administrative workflows with greater precision. Other companies like Plenful and A&A SmartCare also offer solutions for pharmacy optimization.
Validation experiments showed pharmacists preferred Asepha's AI responses over human pharmacist responses 71% of the time. This highlights the technology's effectiveness. The new funding will expand engineering and go-to-market teams. Asepha also plans global partnership expansion and a new New York City office.
The company has already secured multiple Fortune 50 enterprise customers. This establishes its early market importance. Asepha aims to provide meaningful relief to an overstretched pharmacy workforce. Its products improve access for millions of patients. Competitors such as iA also contribute to the evolving landscape of pharmacy technology.
